TNXP SCHEDULE 13G: SEC filing
A Schedule 13G was
Filed with the SEC on · accession 0001167557-26-000168
TNXP filed a SCHEDULE 13G (schedule 13g) with the SEC on Aug 13, 2026. A Schedule 13G was filed regarding Tonix Pharmaceuticals Holding Corp., indicating a passive institutional ownership position. The stock moved +4.4% by the first close after the filing.
Summary of the filing
A Schedule 13G was filed regarding Tonix Pharmaceuticals Holding Corp., indicating a passive institutional ownership position. The filing text provided contains only the EDGAR directory listing and no substantive ownership details.
Key details
How TNXP stock reacted
Close before
$11.97
Aug 12, 2026
First close after
+4.43%
$12.50
5 trading days
+6.35%
$12.73
Since filing
-60.40%
$4.74
✦ Ask GOAX AI about this filing — what it means for TNXP, what changed since its last filings and what to watch next.
Try it free for 7 days🔔 Want to stay updated on new SEC filings for TNXP?
Click hereFrequently asked questions
What did TNXP file with the SEC on Aug 13, 2026?
TNXP filed a SCHEDULE 13G (SEC filing). A Schedule 13G was filed regarding Tonix Pharmaceuticals Holding Corp., indicating a passive institutional ownership position. The filing text provided contains only the EDGAR directory listing and no substantive ownership details.
How do I read a SCHEDULE 13G?
A report the company filed with the SEC (the US market regulator). Start with the summary, then the key amounts and names. Compare it with the company’s earlier filings.
Why are SEC filings important?
Public companies must tell the SEC about anything that can change their value — results, leadership changes, big deals, new shares, bankruptcy. Filings are the official source, often before the news. A SCHEDULE 13G (schedule 13g): A report the company filed with the SEC (the US market regulator).
How did TNXP stock react to this filing?
TNXP closed at $11.97 before the filing and $12.50 on Aug 13, 2026 (+4.43%). Five trading days later: $12.73 (+6.35%).
Other TNXP SEC filings
- 8-K · SEC filingOct 15, 2026
- 8-K · Regulatory actionOct 2, 2026
- 8-K · Contract winSep 22, 2026
- 8-K · Ceo changeSep 8, 2026
- 8-K · Executive departureAug 18, 2026
- SCHEDULE 13G/A · SEC filingAug 14, 2026
- 10-Q · SEC filingAug 10, 2026
- 8-K · Guidance raiseAug 10, 2026
- 8-K · Fda approvalAug 3, 2026
- 8-K · Executive departureJul 21, 2026
Get alerts when TNXP files with the SEC, plus live charts, key levels and news for 13,000+ stocks.
Try SEPT free for 7 days